Prompt injection in pharmaceutical batch reactor exothermic AI

Four adversarial injection surfaces in pharmaceutical batch reactor exothermic AI

1. Batch reactor jacket temperature camera AI (METTLER TOLEDO iC Safety jacket AI, Emerson DeltaV jacket temperature AI, Julabo bath temperature display AI)

The batch reactor jacket — the annular space between the reactor vessel wall and an outer jacket shell, through which a heat transfer fluid (water, glycol-water mixture, or heat transfer oil) circulates at controlled temperature — is the primary mechanism for controlling the temperature of the reaction mixture. During an exothermic reaction, the jacket is maintained at a temperature below the reaction mixture temperature to remove the exothermic heat of reaction; during an endothermic step or at reaction initiation, the jacket is heated to bring the reaction mixture to the setpoint temperature. The temperature differential between the reaction mixture (measured by an immersed thermocouple) and the jacket fluid (measured at the jacket inlet and outlet) encodes the instantaneous heat transfer rate: a large temperature difference between the batch and the jacket (batch significantly hotter than jacket) indicates high exothermic heat generation, while a small or inverted difference (batch cooler than jacket or jacket hotter than batch) indicates endothermic conditions or heat addition. AI systems process rendered jacket temperature instrument displays — digital reading renders of the jacket inlet/outlet temperature, rendered DCS mimic graphics showing the batch temperature trend and jacket temperature trend on a common time axis, or rendered Calometrix or METTLER TOLEDO RC1e calorimeter output displays showing the heat flow rate (in watts) derived from the batch-jacket temperature difference — to classify reaction thermal status: normal (batch-jacket differential within expected exotherm profile for the current synthesis step, heat generation rate within reactor capacity), high exotherm (batch-jacket differential above normal, heat generation rate approaching cooling capacity, reagent addition rate reduction required), runaway precursor (batch-jacket differential and batch temperature trend consistent with accelerating exotherm, immediate emergency quench required), and runaway (batch temperature above solvent boiling point or above decomposition onset temperature, emergency response required).

An adversarial perturbation on a rendered batch reactor jacket temperature display or DCS mimic image that suppresses an emerging exotherm — applying a ±10 DN downward shift to the pixel region encoding the jacket outlet temperature reading or the batch temperature trend trace (reducing the apparent batch-jacket differential from the high-exotherm range to the normal operating range, or normalising the rising batch temperature trend to a flat profile) — causes the jacket temperature AI to classify an accelerating exothermic reaction as normal batch temperature control, suppressing the reagent addition rate reduction and emergency quench that a high-exotherm classification would require. An undetected pharmaceutical synthesis exotherm follows the classic runaway trajectory described in the CSB’s T2 Laboratories investigation (CSB 2008-3-I-FL): as the reaction mixture temperature exceeds the cooling system capacity, the rate of the exothermic reaction increases (according to the Arrhenius equation, reaction rate approximately doubles for every 10°C temperature rise — the Q10 rule), which generates more heat, which raises the temperature further, producing an exponentially accelerating exotherm. In the T2 Laboratories incident, the MCPD reactor batch reached approximately 210°C — above the onset temperature for MCPD decomposition (approximately 200°C) — triggering a secondary decomposition reaction that raised the reactor pressure to above the vessel burst pressure (approximately 450 psi), causing catastrophic vessel failure and a fireball that was visible for miles. The adversarial suppression of the jacket temperature AI output at the early high-exotherm stage — equivalent to the early temperature excursion that T2 operators were unable to diagnose in the incident — removes the only automated warning that would initiate emergency quench before the runaway reaches the Arrhenius acceleration zone.

2. Reflux condenser sight-glass camera AI (Buchi rotary evaporator AI, Heidolph reflux AI, Kemira condenser sight-glass AI)

The reflux condenser — a shell-and-tube or coil heat exchanger positioned above the reactor vessel and connected by the reflux return line — condenses the solvent vapour that evaporates from the reactor contents during exothermic reactions or during intentional reflux operations, returning the condensed solvent to the reactor. The sight-glass on the reflux line — a transparent glass inspection port in the condensate return line between the condenser outlet and the reactor top inlet — provides visual indication of the reflux condensate flow: at normal operating conditions, a steady visible stream of condensed solvent is observed through the sight-glass; under reduced condenser efficiency (insufficient cooling water flow to the condenser, or condenser fouling), the condensate flow rate decreases; under runaway conditions (condenser capacity exceeded by the vapour generation rate from the runaway exotherm), the condensate flow ceases and solvent vapour is vented through the condenser vent. AI systems process rendered camera images of the reflux condenser sight-glass — visible-spectrum camera images showing the liquid flow inside the sight-glass tube — to classify reflux status: normal (steady condensate flow visible, reflux operation normal), reduced flow (condensate flow reduced, condenser efficiency check required), no flow (condensate flow absent, emergency investigation required, possible condenser failure or vapour breakthrough), and vapour breakthrough (no condensate visible, vapour plume at condenser vent, immediate reactor emergency shutdown required). The loss of reflux condensate return to the reactor is one of the earliest visible symptoms of an uncontrolled exotherm: as the reactor heats above the solvent boiling point and the vapour generation rate exceeds condenser capacity, the condensate flow through the sight-glass drops from steady stream to intermittent drips to zero, before solvent vapour appears at the vent — a symptom sequence detectable 5–15 minutes before the reactor reaches decomposition onset temperature in a typical pharmaceutical synthesis runaway trajectory.

An adversarial perturbation on a rendered reflux condenser sight-glass camera image that suppresses a reduced-flow or no-flow condition — applying a ±8 DN upward shift to the pixel region encoding the condensate flow stream in the sight-glass image (rendering the apparent flow as a steady normal stream when the actual condensate flow has ceased, for example by adding texture and luminance to the empty sight-glass image that resembles flowing liquid) — causes the reflux AI to classify a loss-of-condenser-function condition as normal reflux operation, suppressing the emergency investigation and reactor shutdown that a no-flow classification would require. The reflux sight-glass camera AI is particularly important for distillation operations that accompany or follow the synthesis reaction — vacuum distillation, atmospheric reflux, or solvent swap operations — where the concentration of the reaction mixture increases as solvent is removed. Concept Sciences’ 1999 hydroxylamine explosion (CSB 1999-13-C-PA) was directly caused by over-concentration of hydroxylamine during vacuum distillation: the vacuum distillation operation removed water from the aqueous hydroxylamine solution, increasing the hydroxylamine concentration above the threshold (approximately 50% wt) at which the hydroxylamine-oxygen system becomes thermally unstable and self-decomposing. The reflux/distillate sight-glass flow rate is the primary real-time indicator of distillation rate; an adversarial suppression of the sight-glass AI output would allow the distillation to proceed without the operator recognising that the distillation rate is consistent with over-concentration of a thermally sensitive intermediate.

3. PAT NIR spectrometer display AI (ABB MB3600 NIR process AI, Bruker Matrix-F NIR AI, Thermo Scientific Antaris II NIR AI)

Process Analytical Technology (PAT) — the application of in-line, at-line, or on-line analytical instruments to monitor the chemical composition of pharmaceutical batch reactions in real time — was formalised by the FDA in its 2004 PAT Guidance document (“Guidance for Industry: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance”) and is required for real-time release testing under FDA 21 CFR Part 211.68 and ICH Q8 (Pharmaceutical Development). Near-infrared (NIR) spectrometers (ABB MB3600, Bruker Matrix-F, Thermo Scientific Antaris II, Brimrose AOTF NIR) immersed in the batch reactor or in the process stream measure the NIR absorbance spectrum (800–2,500 nm) of the reaction mixture every 30–120 seconds during synthesis, providing real-time quantitative information on: reagent conversion (the fraction of starting material reacted, derived from the absorbance at characteristic reagent absorption bands); product formation (API or intermediate concentration, derived from the absorbance at characteristic product absorption bands); solvent composition (for solvent-swap operations); and water content (derived from the broad O–H stretch overtone at 1,900–2,000 nm). AI systems process rendered NIR spectrometer display images — rendered spectrometer software output displays showing the current NIR spectrum overlay and the trend of modeled composition versus time — to classify batch reaction endpoint status: in-progress (reagent conversion below endpoint specification, batch continues), approaching endpoint (reagent conversion within pre-endpoint window, addition of next reagent or workup step preparation required), endpoint reached (reagent conversion at or above specification, next batch step can proceed), and OOS endpoint (conversion outside specification bounds, batch deviation investigation required per FDA 21 CFR Part 211.192).

An adversarial perturbation on a rendered PAT NIR spectrometer display image that artificially elevates the displayed reagent conversion — applying a ±10 DN shift to the pixel region encoding the conversion trend trace or the endpoint confirmation indicator (rendering the apparent conversion as having reached or exceeded the endpoint specification when actual conversion is still below specification) — causes the PAT endpoint AI to classify an incomplete batch reaction as having reached the API synthesis endpoint, triggering premature progression to the workup or isolation step. A pharmaceutical API batch stopped before the synthesis reaction is complete produces a product mixture containing unreacted starting materials, reaction intermediates, and incompletely converted reagents alongside the target API — all of which will be carried through the workup and isolation steps if the incomplete reaction is not detected. The resulting API batch may contain genotoxic impurities (if the unreacted reagent is a potentially mutagenic compound, such as an alkylating agent used in many oncology API syntheses), above-ICH M7 limits for nitrosamine impurities (if the unreacted nitrosating reagent is present), or above-ICH Q3C residual solvent limits — all of which would cause the batch to fail FDA 21 CFR Part 211.194 final release testing but only if the out-of-specification (OOS) investigation triggered by the failed test result is connected to the early batch stop — a connection that may not be made if the PAT endpoint AI failure is not identified in the batch record review. FDA 21 CFR Part 211.192 requires investigation of any unexplained discrepancy or failure to meet specifications, but does not require evaluation of whether AI systems processing rendered PAT display images are adversarially robust.

4. API crystallizer slurry level camera AI (METTLER TOLEDO EasyMax crystallizer AI, Julabo crystallization AI, Lauda cooling crystallizer AI)

API isolation from the batch reaction mixture typically involves crystallisation — a controlled cooling or antisolvent addition process in which the API is precipitated from the reaction mixture solution as a solid crystalline product with defined particle size distribution (PSD), crystal form (polymorph), and purity. The crystallizer vessel — a jacketed tank with a slow-speed agitator — maintains the slurry (suspension of API crystals in the mother liquor) at a controlled temperature during the crystallisation step and during the subsequent slurry transfer to the centrifuge or filter for solid-liquid separation. The slurry level in the crystallizer — the height of the slurry in the vessel — is monitored by level instruments or camera systems to control the slurry transfer timing: if slurry transfer begins too early (insufficient crystallisation time), the crystal yield is below maximum; if transfer is delayed beyond the intended endpoint, the crystal PSD may broaden or the polymorph distribution may shift due to continued cooling and crystal growth. More critically, if the slurry level rises above the maximum operating level (due to excess antisolvent addition or exothermic heat of crystallisation causing thermal expansion of the slurry), the slurry can overflow through the crystallizer vent or through agitator shaft seals, releasing API-containing mother liquor (often a mixture of organic solvents — ethanol, methanol, acetonitrile, isopropanol) into the plant area, creating a flammable atmosphere that is subject to OSHA PSM TQ limits for flammable solvents. AI systems process rendered camera images of the crystallizer slurry level — including rendered sight-glass camera images, rendered level instrument display images, or rendered DCS level trend displays — to classify crystallizer status: normal (slurry level within operating range, crystallisation proceeding), low (slurry level below minimum, antisolvent addition check required), high (slurry level above maximum, antisolvent addition stop and level investigation required), and critically high (slurry level at overflow threshold, immediate antisolvent stop and vent scrubber preparation required).

An adversarial perturbation on a rendered crystallizer slurry level camera image that suppresses a high-level condition — applying a ±10 DN downward shift to the pixel region encoding the slurry level position in the sight-glass camera image or level display (reducing the apparent slurry level from the high or critically-high range to the normal operating band) — causes the crystallizer level AI to classify a near-overflow slurry condition as normal, suppressing the antisolvent addition stop and emergency level management that a high-level classification would require. API crystallizer overflow releases organic solvent mother liquor (typically a flammable organic solvent at –20 to 0°C for cold crystallisations, or at 0–40°C for ambient crystallisations) into the pharmaceutical manufacturing suite. Flammable solvent spills in pharmaceutical manufacturing suites — which typically contain ex-rated electrical equipment, but may also have heat sources (jacketed crystallizer heating elements) or non-ex-rated equipment in adjacent areas — create fire and explosion risks that are subject to OSHA 1910.106 (Flammable Liquids) and OSHA 1910.119 PSM requirements when solvent quantities exceed TQ limits. The FDA 21 CFR Part 211 GMP consequence of an undetected crystallizer overflow is a production deviation that requires investigation, documentation, and potential batch rejection — and if the overflow contaminates the manufacturing suite with API-containing mother liquor, a cross-contamination investigation is required before the suite can be returned to cGMP production status.

Integration: pharmaceutical batch reactor AI scanning with Glyphward pre-scan gate

The Glyphward scan gate for pharmaceutical batch reactor AI belongs at every rendered-image ingestion boundary in the batch reaction monitoring pipeline — before batch reactor jacket temperature AI processes rendered temperature instrument images, before reflux condenser sight-glass AI processes rendered sight-glass camera images, before PAT NIR spectrometer display AI processes rendered spectrometer output images, and before API crystallizer slurry level AI processes rendered level instrument images. Threshold 35 for pharmaceutical batch reactor AI contexts reflects the OSHA PSM reactive hazard and FDA 21 CFR GMP consequence envelope of batch runaway (T2 Laboratories 2007: 4 killed; Concept Sciences 1999: 5 killed) and OOS API release at facilities synthesising APIs under OSHA PSM flammable solvent TQ limits.

import asyncio, base64, hashlib, json
from datetime import datetime, timezone
from enum import Enum
from pathlib import Path

import httpx

GLYPHWARD_API_KEY = "YOUR_GLYPHWARD_API_KEY"
GLYPHWARD_SCAN_URL = "https://glyphward.com/v1/scan"

# Pharmaceutical batch reactor AI contexts: threshold 35
# OSHA PSM 29 CFR 1910.119 (reactive hazards; flammable solvent TQ 10,000 lb);
# FDA 21 CFR Part 211 (GMP for finished pharmaceuticals);
# FDA PAT Guidance 2004 (Process Analytical Technology);
# ICH Q8 (Pharmaceutical Development);
# ICH M7 (Genotoxic Impurities).
PHARMA_BATCH_REACTOR_THRESHOLD = 35


class PharmaBatchReactorAIContext(Enum):
    JACKET_TEMPERATURE  = "jacket_temperature"  # Reactor jacket temperature camera AI
    REFLUX_SIGHT_GLASS  = "reflux_sight_glass"  # Reflux condenser sight-glass camera AI
    PAT_NIR_ENDPOINT    = "pat_nir_endpoint"    # PAT NIR spectrometer display AI
    CRYSTALLIZER_LEVEL  = "crystallizer_level"  # API crystallizer slurry level camera AI


class AdversarialPharmaBatchReactorImageError(Exception):
    """Raised when Glyphward detects adversarial content in a pharmaceutical
    batch reactor AI rendered image above threshold 35.

    Consequence if not raised:
    - JACKET_TEMPERATURE: exotherm signature suppressed → Arrhenius
      acceleration undetected → batch reactor runaway → vessel burst →
      solvent fireball. T2 Laboratories 2007: 4 killed, 32 injured.
    - REFLUX_SIGHT_GLASS: condenser loss-of-function suppressed →
      solvent over-concentration undetected → Concept Sciences 1999
      mechanism (5 killed) for thermally sensitive intermediates.
    - PAT_NIR_ENDPOINT: premature endpoint call → incomplete synthesis →
      genotoxic impurity (ICH M7), nitrosamine, or residual solvent
      (ICH Q3C) OOS in shipped API; FDA 21 CFR Part 211.192 deviation.
    - CRYSTALLIZER_LEVEL: overflow suppressed → flammable solvent spill
      in manufacturing suite → fire/explosion; cGMP cross-contamination
      requiring batch rejection and suite remediation.
    Fail-safe: halt pharmaceutical batch reactor AI classification;
    require manual instrument verification per OSHA PSM reactive hazard
    emergency procedures and FDA 21 CFR Part 211 batch deviation
    documentation before resuming AI-driven batch management.
    """

    def __init__(self, scan_id: str, score: int,
                 context: PharmaBatchReactorAIContext,
                 facility_id: str, batch_id: str,
                 flagged_region: dict | None = None) -> None:
        self.scan_id = scan_id
        self.score = score
        self.context = context
        self.facility_id = facility_id
        self.batch_id = batch_id
        self.flagged_region = flagged_region
        super().__init__(
            f"Adversarial pharma batch reactor image: "
            f"context={context.value} score={score} "
            f"facility={facility_id} batch={batch_id} scan_id={scan_id}"
        )


async def scan_pharma_batch_reactor_image(
    image_bytes: bytes,
    context: PharmaBatchReactorAIContext,
    facility_id: str,
    batch_id: str,
    api_name: str | None,
    client: httpx.AsyncClient,
) -> dict:
    """Scan a pharmaceutical batch reactor AI rendered image for adversarial
    content.

    Fail-safe contract: AdversarialPharmaBatchReactorImageError or httpx
    error → halt pharmaceutical batch reactor AI classification for the
    affected batch; require manual instrument verification (JACKET_TEMPERATURE:
    manual thermocouple reading + emergency quench preparation per OSHA PSM
    reactive hazard emergency response plan; REFLUX_SIGHT_GLASS: manual sight-
    glass visual check + distillation rate manual calculation; PAT_NIR_ENDPOINT:
    manual NIR sample analysis per FDA 21 CFR Part 211.68; CRYSTALLIZER_LEVEL:
    manual level gauge reading + antisolvent addition halt) before resuming
    AI-driven batch management decisions.
    """
    image_hash = hashlib.sha256(image_bytes).hexdigest()
    payload = {
        "image": base64.b64encode(image_bytes).decode(),
        "source": f"pharma_batch:{context.value}:{facility_id}:{batch_id}",
        "metadata": {
            "facility_id": facility_id,
            "batch_id": batch_id,
            "context": context.value,
            "api_name": api_name,
            "image_sha256": image_hash,
        },
    }
    resp = await client.post(
        GLYPHWARD_SCAN_URL,
        headers={"Authorization": f"Bearer {GLYPHWARD_API_KEY}"},
        json=payload,
        timeout=4.0,
    )
    resp.raise_for_status()
    result = resp.json()

    if result["score"] > PHARMA_BATCH_REACTOR_THRESHOLD:
        raise AdversarialPharmaBatchReactorImageError(
            scan_id=result["scan_id"],
            score=result["score"],
            context=context,
            facility_id=facility_id,
            batch_id=batch_id,
            flagged_region=result.get("flagged_region"),
        )
    return result

Deploy scan_pharma_batch_reactor_image at each pharmaceutical batch reactor AI rendered-image ingestion boundary: before batch reactor jacket temperature AI (threshold 35), before reflux condenser sight-glass AI (threshold 35), before PAT NIR spectrometer display AI (threshold 35), and before API crystallizer slurry level AI (threshold 35). On AdversarialPharmaBatchReactorImageError for JACKET_TEMPERATURE context: immediately initiate emergency quench per the facility’s OSHA PSM reactive hazard emergency response plan and halt reagent addition before resuming AI-driven batch temperature management. See also: chemical plant process safety AI prompt injection (related OSHA PSM reactive hazard AI context) and pharmaceutical drug manufacturing GMP AI prompt injection (related FDA 21 CFR Part 211 quality AI context). Get early access

Related questions